New trends in patient management: risk-based therapy for febrile patients with neutropenia
Clicks: 348
ID: 111956
1999
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
71.3
/100
338 views
274 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Standard management of febrile neutropenia includes the prompt administration of empirical, broad-spectrum, parenteral antibiotic therapy. This is generally done in a hospital-based setting. Although effective (overall survival of >90%), such therapy leads to prolonged hospitalization, excessive …
| Reference Key |
kv1999clinicalnew
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Rolston KV;; |
| Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Year | 1999 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Administration
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
prognosis
female
male
anti-bacterial agents / administration & dosage*
risk assessment
bacterial infections / complications
bacterial infections / drug therapy*
fever / prevention & control*
neutropenia / prevention & control*
patient selection
oral
pmid:10530438
doi:10.1086/598624
k v rolston
ambulatory care / trends*
fever / complications
neoplasms / complications
neutropenia / complications
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.